nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—NR3C1—epilepsy syndrome	0.619	1	CbGaD
Fluocinonide—SERPINA6—hindbrain—epilepsy syndrome	0.00528	0.108	CbGeAlD
Fluocinonide—SMO—medulla oblongata—epilepsy syndrome	0.00383	0.0781	CbGeAlD
Fluocinonide—SMO—midbrain—epilepsy syndrome	0.0035	0.0714	CbGeAlD
Fluocinonide—SMO—spinal cord—epilepsy syndrome	0.00342	0.0696	CbGeAlD
Fluocinonide—SMO—head—epilepsy syndrome	0.00304	0.0619	CbGeAlD
Fluocinonide—SMO—nervous system—epilepsy syndrome	0.00288	0.0587	CbGeAlD
Fluocinonide—SMO—central nervous system—epilepsy syndrome	0.00277	0.0565	CbGeAlD
Fluocinonide—SMO—cerebellum—epilepsy syndrome	0.00271	0.0552	CbGeAlD
Fluocinonide—NR3C1—hindbrain—epilepsy syndrome	0.00231	0.0471	CbGeAlD
Fluocinonide—SMO—brain—epilepsy syndrome	0.0022	0.0448	CbGeAlD
Fluocinonide—SERPINA6—head—epilepsy syndrome	0.00167	0.0341	CbGeAlD
Fluocinonide—SERPINA6—nervous system—epilepsy syndrome	0.00159	0.0323	CbGeAlD
Fluocinonide—SERPINA6—central nervous system—epilepsy syndrome	0.00153	0.0311	CbGeAlD
Fluocinonide—SERPINA6—cerebellum—epilepsy syndrome	0.00149	0.0304	CbGeAlD
Fluocinonide—NR3C1—brainstem—epilepsy syndrome	0.00133	0.027	CbGeAlD
Fluocinonide—NR3C1—forebrain—epilepsy syndrome	0.00128	0.0261	CbGeAlD
Fluocinonide—SERPINA6—brain—epilepsy syndrome	0.00121	0.0247	CbGeAlD
Fluocinonide—NR3C1—telencephalon—epilepsy syndrome	0.00118	0.024	CbGeAlD
Fluocinonide—NR3C1—medulla oblongata—epilepsy syndrome	0.000925	0.0188	CbGeAlD
Fluocinonide—Swelling—Valproic Acid—epilepsy syndrome	0.0009	0.00423	CcSEcCtD
Fluocinonide—Hypersensitivity—Amobarbital—epilepsy syndrome	0.00087	0.00409	CcSEcCtD
Fluocinonide—Skin exfoliation—Gabapentin—epilepsy syndrome	0.000866	0.00407	CcSEcCtD
Fluocinonide—Infection—Rufinamide—epilepsy syndrome	0.000864	0.00406	CcSEcCtD
Fluocinonide—Nervous system disorder—Rufinamide—epilepsy syndrome	0.000853	0.00401	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Lacosamide—epilepsy syndrome	0.000846	0.00397	CcSEcCtD
Fluocinonide—NR3C1—midbrain—epilepsy syndrome	0.000845	0.0172	CbGeAlD
Fluocinonide—Skin disorder—Rufinamide—epilepsy syndrome	0.000845	0.00397	CcSEcCtD
Fluocinonide—Hyperglycaemia—Phenytoin—epilepsy syndrome	0.000845	0.00397	CcSEcCtD
Fluocinonide—Hyperglycaemia—Oxcarbazepine—epilepsy syndrome	0.00084	0.00395	CcSEcCtD
Fluocinonide—NR3C1—spinal cord—epilepsy syndrome	0.000825	0.0168	CbGeAlD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Clobazam—epilepsy syndrome	0.000821	0.00386	CcSEcCtD
Fluocinonide—Immune system disorder—Midazolam—epilepsy syndrome	0.000816	0.00383	CcSEcCtD
Fluocinonide—Hyperglycaemia—Carbamazepine—epilepsy syndrome	0.000806	0.00379	CcSEcCtD
Fluocinonide—Immune system disorder—Levetiracetam—epilepsy syndrome	0.000806	0.00379	CcSEcCtD
Fluocinonide—Erythema—Propofol—epilepsy syndrome	0.000804	0.00378	CcSEcCtD
Fluocinonide—Nervous system disorder—Lacosamide—epilepsy syndrome	0.000801	0.00376	CcSEcCtD
Fluocinonide—Skin disorder—Lacosamide—epilepsy syndrome	0.000793	0.00373	CcSEcCtD
Fluocinonide—Nasal congestion—Pregabalin—epilepsy syndrome	0.000788	0.0037	CcSEcCtD
Fluocinonide—Infection—Clobazam—epilepsy syndrome	0.000787	0.0037	CcSEcCtD
Fluocinonide—Erythema—Midazolam—epilepsy syndrome	0.000786	0.0037	CcSEcCtD
Fluocinonide—Dizziness—Amobarbital—epilepsy syndrome	0.000781	0.00367	CcSEcCtD
Fluocinonide—Hyperglycaemia—Lamotrigine—epilepsy syndrome	0.000779	0.00366	CcSEcCtD
Fluocinonide—Nervous system disorder—Clobazam—epilepsy syndrome	0.000777	0.00365	CcSEcCtD
Fluocinonide—Skin disorder—Clobazam—epilepsy syndrome	0.00077	0.00362	CcSEcCtD
Fluocinonide—Pain—Phenobarbital—epilepsy syndrome	0.000758	0.00356	CcSEcCtD
Fluocinonide—Dizziness—Primidone—epilepsy syndrome	0.000752	0.00353	CcSEcCtD
Fluocinonide—Swelling—Gabapentin—epilepsy syndrome	0.000746	0.00351	CcSEcCtD
Fluocinonide—Rash—Amobarbital—epilepsy syndrome	0.000744	0.0035	CcSEcCtD
Fluocinonide—Dermatitis—Amobarbital—epilepsy syndrome	0.000744	0.00349	CcSEcCtD
Fluocinonide—Headache—Amobarbital—epilepsy syndrome	0.000739	0.00347	CcSEcCtD
Fluocinonide—NR3C1—head—epilepsy syndrome	0.000733	0.0149	CbGeAlD
Fluocinonide—Dry skin—Valproic Acid—epilepsy syndrome	0.000728	0.00342	CcSEcCtD
Fluocinonide—Erythema—Diazepam—epilepsy syndrome	0.000719	0.00338	CcSEcCtD
Fluocinonide—Rash—Primidone—epilepsy syndrome	0.000717	0.00337	CcSEcCtD
Fluocinonide—Dermatitis—Primidone—epilepsy syndrome	0.000716	0.00337	CcSEcCtD
Fluocinonide—Headache—Primidone—epilepsy syndrome	0.000712	0.00335	CcSEcCtD
Fluocinonide—Pruritus—Trimethadione—epilepsy syndrome	0.000708	0.00333	CcSEcCtD
Fluocinonide—Immune system disorder—Zonisamide—epilepsy syndrome	0.000707	0.00332	CcSEcCtD
Fluocinonide—NR3C1—nervous system—epilepsy syndrome	0.000695	0.0141	CbGeAlD
Fluocinonide—Immune system disorder—Clonazepam—epilepsy syndrome	0.000681	0.0032	CcSEcCtD
Fluocinonide—Immune system disorder—Phenytoin—epilepsy syndrome	0.000677	0.00318	CcSEcCtD
Fluocinonide—Immune system disorder—Oxcarbazepine—epilepsy syndrome	0.000673	0.00316	CcSEcCtD
Fluocinonide—NR3C1—central nervous system—epilepsy syndrome	0.000669	0.0136	CbGeAlD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Midazolam—epilepsy syndrome	0.000665	0.00312	CcSEcCtD
Fluocinonide—Dry skin—Pregabalin—epilepsy syndrome	0.000658	0.00309	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Levetiracetam—epilepsy syndrome	0.000657	0.00309	CcSEcCtD
Fluocinonide—NR3C1—cerebellum—epilepsy syndrome	0.000654	0.0133	CbGeAlD
Fluocinonide—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000653	0.00307	CcSEcCtD
Fluocinonide—Immune system disorder—Carbamazepine—epilepsy syndrome	0.000646	0.00304	CcSEcCtD
Fluocinonide—Nasopharyngitis—Pregabalin—epilepsy syndrome	0.000642	0.00302	CcSEcCtD
Fluocinonide—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000641	0.00301	CcSEcCtD
Fluocinonide—Rash—Trimethadione—epilepsy syndrome	0.000631	0.00296	CcSEcCtD
Fluocinonide—Dermatitis—Trimethadione—epilepsy syndrome	0.00063	0.00296	CcSEcCtD
Fluocinonide—Infection—Levetiracetam—epilepsy syndrome	0.00063	0.00296	CcSEcCtD
Fluocinonide—Nervous system disorder—Midazolam—epilepsy syndrome	0.000629	0.00296	CcSEcCtD
Fluocinonide—Headache—Trimethadione—epilepsy syndrome	0.000627	0.00294	CcSEcCtD
Fluocinonide—Skin disorder—Midazolam—epilepsy syndrome	0.000623	0.00293	CcSEcCtD
Fluocinonide—Erythema—Carbamazepine—epilepsy syndrome	0.000623	0.00293	CcSEcCtD
Fluocinonide—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000622	0.00292	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	0.000618	0.0029	CcSEcCtD
Fluocinonide—Skin disorder—Levetiracetam—epilepsy syndrome	0.000616	0.00289	CcSEcCtD
Fluocinonide—Pruritus—Rufinamide—epilepsy syndrome	0.000615	0.00289	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	0.000608	0.00286	CcSEcCtD
Fluocinonide—Nasal congestion—Topiramate—epilepsy syndrome	0.000608	0.00286	CcSEcCtD
Fluocinonide—Infection—Fosphenytoin—epilepsy syndrome	0.000608	0.00286	CcSEcCtD
Fluocinonide—Dry skin—Gabapentin—epilepsy syndrome	0.000603	0.00284	CcSEcCtD
Fluocinonide—Erythema—Lamotrigine—epilepsy syndrome	0.000602	0.00283	CcSEcCtD
Fluocinonide—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000602	0.00283	CcSEcCtD
Fluocinonide—Infection—Vigabatrin—epilepsy syndrome	0.000592	0.00278	CcSEcCtD
Fluocinonide—Nasopharyngitis—Gabapentin—epilepsy syndrome	0.000589	0.00277	CcSEcCtD
Fluocinonide—Dizziness—Phenobarbital—epilepsy syndrome	0.000586	0.00275	CcSEcCtD
Fluocinonide—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000585	0.00275	CcSEcCtD
Fluocinonide—Infection—Diazepam—epilepsy syndrome	0.000583	0.00274	CcSEcCtD
Fluocinonide—Skin disorder—Vigabatrin—epilepsy syndrome	0.000579	0.00272	CcSEcCtD
Fluocinonide—Pruritus—Lacosamide—epilepsy syndrome	0.000578	0.00271	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.000576	0.00271	CcSEcCtD
Fluocinonide—Nervous system disorder—Diazepam—epilepsy syndrome	0.000576	0.00271	CcSEcCtD
Fluocinonide—Dizziness—Rufinamide—epilepsy syndrome	0.000575	0.0027	CcSEcCtD
Fluocinonide—Skin disorder—Diazepam—epilepsy syndrome	0.00057	0.00268	CcSEcCtD
Fluocinonide—Infection—Felbamate—epilepsy syndrome	0.000564	0.00265	CcSEcCtD
Fluocinonide—Pain—Propofol—epilepsy syndrome	0.000561	0.00264	CcSEcCtD
Fluocinonide—Pruritus—Clobazam—epilepsy syndrome	0.000561	0.00263	CcSEcCtD
Fluocinonide—Hyperglycaemia—Pregabalin—epilepsy syndrome	0.00056	0.00263	CcSEcCtD
Fluocinonide—Rash—Phenobarbital—epilepsy syndrome	0.000559	0.00262	CcSEcCtD
Fluocinonide—Dermatitis—Phenobarbital—epilepsy syndrome	0.000558	0.00262	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.000555	0.00261	CcSEcCtD
Fluocinonide—Headache—Phenobarbital—epilepsy syndrome	0.000555	0.00261	CcSEcCtD
Fluocinonide—Infection—Zonisamide—epilepsy syndrome	0.000553	0.0026	CcSEcCtD
Fluocinonide—Pain—Midazolam—epilepsy syndrome	0.000549	0.00258	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.000549	0.00258	CcSEcCtD
Fluocinonide—Rash—Rufinamide—epilepsy syndrome	0.000548	0.00258	CcSEcCtD
Fluocinonide—Dermatitis—Rufinamide—epilepsy syndrome	0.000548	0.00257	CcSEcCtD
Fluocinonide—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000545	0.00256	CcSEcCtD
Fluocinonide—Headache—Rufinamide—epilepsy syndrome	0.000545	0.00256	CcSEcCtD
Fluocinonide—Pain—Levetiracetam—epilepsy syndrome	0.000542	0.00255	CcSEcCtD
Fluocinonide—Skin disorder—Zonisamide—epilepsy syndrome	0.00054	0.00254	CcSEcCtD
Fluocinonide—Dizziness—Lacosamide—epilepsy syndrome	0.00054	0.00254	CcSEcCtD
Fluocinonide—Infection—Clonazepam—epilepsy syndrome	0.000533	0.0025	CcSEcCtD
Fluocinonide—NR3C1—brain—epilepsy syndrome	0.000531	0.0108	CbGeAlD
Fluocinonide—Infection—Phenytoin—epilepsy syndrome	0.000529	0.00249	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000527	0.00247	CcSEcCtD
Fluocinonide—Infection—Oxcarbazepine—epilepsy syndrome	0.000526	0.00247	CcSEcCtD
Fluocinonide—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000526	0.00247	CcSEcCtD
Fluocinonide—Dizziness—Clobazam—epilepsy syndrome	0.000524	0.00246	CcSEcCtD
Fluocinonide—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000522	0.00245	CcSEcCtD
Fluocinonide—Skin disorder—Clonazepam—epilepsy syndrome	0.000521	0.00245	CcSEcCtD
Fluocinonide—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000519	0.00244	CcSEcCtD
Fluocinonide—Rash—Lacosamide—epilepsy syndrome	0.000515	0.00242	CcSEcCtD
Fluocinonide—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000514	0.00242	CcSEcCtD
Fluocinonide—Dermatitis—Lacosamide—epilepsy syndrome	0.000514	0.00242	CcSEcCtD
Fluocinonide—Hyperglycaemia—Gabapentin—epilepsy syndrome	0.000513	0.00241	CcSEcCtD
Fluocinonide—Headache—Lacosamide—epilepsy syndrome	0.000512	0.0024	CcSEcCtD
Fluocinonide—Pain—Vigabatrin—epilepsy syndrome	0.00051	0.0024	CcSEcCtD
Fluocinonide—Infection—Carbamazepine—epilepsy syndrome	0.000505	0.00237	CcSEcCtD
Fluocinonide—Pain—Diazepam—epilepsy syndrome	0.000502	0.00236	CcSEcCtD
Fluocinonide—Rash—Clobazam—epilepsy syndrome	0.0005	0.00235	CcSEcCtD
Fluocinonide—Dermatitis—Clobazam—epilepsy syndrome	0.000499	0.00235	CcSEcCtD
Fluocinonide—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000498	0.00234	CcSEcCtD
Fluocinonide—Headache—Clobazam—epilepsy syndrome	0.000496	0.00233	CcSEcCtD
Fluocinonide—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000496	0.00233	CcSEcCtD
Fluocinonide—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000495	0.00233	CcSEcCtD
Fluocinonide—Skin disorder—Carbamazepine—epilepsy syndrome	0.000494	0.00232	CcSEcCtD
Fluocinonide—Infection—Lamotrigine—epilepsy syndrome	0.000488	0.00229	CcSEcCtD
Fluocinonide—Pain—Felbamate—epilepsy syndrome	0.000486	0.00228	CcSEcCtD
Fluocinonide—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000482	0.00226	CcSEcCtD
Fluocinonide—Hypersensitivity—Midazolam—epilepsy syndrome	0.000473	0.00222	CcSEcCtD
Fluocinonide—Dizziness—Acetazolamide—epilepsy syndrome	0.000467	0.00219	CcSEcCtD
Fluocinonide—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000467	0.00219	CcSEcCtD
Fluocinonide—Pruritus—Propofol—epilepsy syndrome	0.000464	0.00218	CcSEcCtD
Fluocinonide—Pain—Clonazepam—epilepsy syndrome	0.000458	0.00215	CcSEcCtD
Fluocinonide—Pruritus—Midazolam—epilepsy syndrome	0.000454	0.00213	CcSEcCtD
Fluocinonide—Pain—Oxcarbazepine—epilepsy syndrome	0.000453	0.00213	CcSEcCtD
Fluocinonide—Immune system disorder—Pregabalin—epilepsy syndrome	0.000449	0.00211	CcSEcCtD
Fluocinonide—Pruritus—Levetiracetam—epilepsy syndrome	0.000448	0.00211	CcSEcCtD
Fluocinonide—Headache—Acetazolamide—epilepsy syndrome	0.000443	0.00208	CcSEcCtD
Fluocinonide—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000439	0.00206	CcSEcCtD
Fluocinonide—Pain—Carbamazepine—epilepsy syndrome	0.000435	0.00204	CcSEcCtD
Fluocinonide—Dizziness—Propofol—epilepsy syndrome	0.000434	0.00204	CcSEcCtD
Fluocinonide—Pruritus—Fosphenytoin—epilepsy syndrome	0.000433	0.00203	CcSEcCtD
Fluocinonide—Hypersensitivity—Diazepam—epilepsy syndrome	0.000433	0.00203	CcSEcCtD
Fluocinonide—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000432	0.00203	CcSEcCtD
Fluocinonide—Dizziness—Midazolam—epilepsy syndrome	0.000424	0.00199	CcSEcCtD
Fluocinonide—Pruritus—Vigabatrin—epilepsy syndrome	0.000422	0.00198	CcSEcCtD
Fluocinonide—Pain—Lamotrigine—epilepsy syndrome	0.00042	0.00197	CcSEcCtD
Fluocinonide—Dizziness—Levetiracetam—epilepsy syndrome	0.000419	0.00197	CcSEcCtD
Fluocinonide—Pruritus—Diazepam—epilepsy syndrome	0.000415	0.00195	CcSEcCtD
Fluocinonide—Rash—Propofol—epilepsy syndrome	0.000414	0.00194	CcSEcCtD
Fluocinonide—Dermatitis—Propofol—epilepsy syndrome	0.000413	0.00194	CcSEcCtD
Fluocinonide—Immune system disorder—Gabapentin—epilepsy syndrome	0.000411	0.00193	CcSEcCtD
Fluocinonide—Headache—Propofol—epilepsy syndrome	0.000411	0.00193	CcSEcCtD
Fluocinonide—Difluprednate—NR3C1—epilepsy syndrome	0.00041	0.0464	CrCbGaD
Fluocinonide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00041	0.00193	CcSEcCtD
Fluocinonide—Rash—Midazolam—epilepsy syndrome	0.000405	0.0019	CcSEcCtD
Fluocinonide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000405	0.0019	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000404	0.0019	CcSEcCtD
Fluocinonide—Dermatitis—Midazolam—epilepsy syndrome	0.000404	0.0019	CcSEcCtD
Fluocinonide—Headache—Midazolam—epilepsy syndrome	0.000402	0.00189	CcSEcCtD
Fluocinonide—Pruritus—Felbamate—epilepsy syndrome	0.000402	0.00189	CcSEcCtD
Fluocinonide—Rash—Levetiracetam—epilepsy syndrome	0.0004	0.00188	CcSEcCtD
Fluocinonide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000399	0.00188	CcSEcCtD
Fluocinonide—Clocortolone—NR3C1—epilepsy syndrome	0.000398	0.045	CrCbGaD
Fluocinonide—Headache—Levetiracetam—epilepsy syndrome	0.000397	0.00187	CcSEcCtD
Fluocinonide—Erythema—Gabapentin—epilepsy syndrome	0.000396	0.00186	CcSEcCtD
Fluocinonide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000395	0.00186	CcSEcCtD
Fluocinonide—Dizziness—Vigabatrin—epilepsy syndrome	0.000394	0.00185	CcSEcCtD
Fluocinonide—Pruritus—Zonisamide—epilepsy syndrome	0.000394	0.00185	CcSEcCtD
Fluocinonide—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000392	0.00184	CcSEcCtD
Fluocinonide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00039	0.00183	CcSEcCtD
Fluocinonide—Dizziness—Diazepam—epilepsy syndrome	0.000388	0.00182	CcSEcCtD
Fluocinonide—Infection—Valproic Acid—epilepsy syndrome	0.000388	0.00182	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CCR3—epilepsy syndrome	0.000387	0.00351	CbGpPWpGaD
Fluocinonide—Rash—Fosphenytoin—epilepsy syndrome	0.000386	0.00181	CcSEcCtD
Fluocinonide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000385	0.00181	CcSEcCtD
Fluocinonide—Headache—Fosphenytoin—epilepsy syndrome	0.000383	0.0018	CcSEcCtD
Fluocinonide—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000383	0.0018	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.00038	0.00345	CbGpPWpGaD
Fluocinonide—Pruritus—Clonazepam—epilepsy syndrome	0.000379	0.00178	CcSEcCtD
Fluocinonide—Skin disorder—Valproic Acid—epilepsy syndrome	0.000379	0.00178	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—NPY—epilepsy syndrome	0.000377	0.00342	CbGpPWpGaD
Fluocinonide—Pruritus—Phenytoin—epilepsy syndrome	0.000377	0.00177	CcSEcCtD
Fluocinonide—Desonide—NR3C1—epilepsy syndrome	0.000376	0.0426	CrCbGaD
Fluocinonide—Diflorasone—NR3C1—epilepsy syndrome	0.000376	0.0426	CrCbGaD
Fluocinonide—Rash—Vigabatrin—epilepsy syndrome	0.000376	0.00177	CcSEcCtD
Fluocinonide—Dizziness—Felbamate—epilepsy syndrome	0.000376	0.00177	CcSEcCtD
Fluocinonide—Dermatitis—Vigabatrin—epilepsy syndrome	0.000376	0.00177	CcSEcCtD
Fluocinonide—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000375	0.00176	CcSEcCtD
Fluocinonide—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000374	0.00176	CcSEcCtD
Fluocinonide—Headache—Vigabatrin—epilepsy syndrome	0.000374	0.00176	CcSEcCtD
Fluocinonide—Rash—Diazepam—epilepsy syndrome	0.00037	0.00174	CcSEcCtD
Fluocinonide—Dermatitis—Diazepam—epilepsy syndrome	0.00037	0.00174	CcSEcCtD
Fluocinonide—Dizziness—Zonisamide—epilepsy syndrome	0.000368	0.00173	CcSEcCtD
Fluocinonide—Headache—Diazepam—epilepsy syndrome	0.000368	0.00173	CcSEcCtD
Fluocinonide—Desoximetasone—NR3C1—epilepsy syndrome	0.000367	0.0415	CrCbGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000366	0.00172	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—OXT—epilepsy syndrome	0.000364	0.0033	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL3—epilepsy syndrome	0.000364	0.0033	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CRH—epilepsy syndrome	0.000364	0.0033	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000364	0.0033	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.000362	0.00329	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000362	0.0017	CcSEcCtD
Fluocinonide—Pruritus—Carbamazepine—epilepsy syndrome	0.00036	0.00169	CcSEcCtD
Fluocinonide—Rash—Felbamate—epilepsy syndrome	0.000358	0.00168	CcSEcCtD
Fluocinonide—Dermatitis—Felbamate—epilepsy syndrome	0.000358	0.00168	CcSEcCtD
Fluocinonide—Headache—Felbamate—epilepsy syndrome	0.000356	0.00167	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—GRM2—epilepsy syndrome	0.000355	0.00322	CbGpPWpGaD
Fluocinonide—Dizziness—Clonazepam—epilepsy syndrome	0.000354	0.00167	CcSEcCtD
Fluocinonide—Dizziness—Phenytoin—epilepsy syndrome	0.000352	0.00165	CcSEcCtD
Fluocinonide—Rash—Zonisamide—epilepsy syndrome	0.000351	0.00165	CcSEcCtD
Fluocinonide—Infection—Pregabalin—epilepsy syndrome	0.000351	0.00165	CcSEcCtD
Fluocinonide—Dermatitis—Zonisamide—epilepsy syndrome	0.00035	0.00165	CcSEcCtD
Fluocinonide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00035	0.00165	CcSEcCtD
Fluocinonide—Headache—Zonisamide—epilepsy syndrome	0.000348	0.00164	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.000348	0.00316	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.000348	0.00316	CbGpPWpGaD
Fluocinonide—Pruritus—Lamotrigine—epilepsy syndrome	0.000348	0.00163	CcSEcCtD
Fluocinonide—Immune system disorder—Topiramate—epilepsy syndrome	0.000346	0.00163	CcSEcCtD
Fluocinonide—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000346	0.00163	CcSEcCtD
Fluocinonide—Skin disorder—Pregabalin—epilepsy syndrome	0.000343	0.00161	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.000341	0.0031	CbGpPWpGaD
Fluocinonide—Rash—Clonazepam—epilepsy syndrome	0.000338	0.00159	CcSEcCtD
Fluocinonide—Dermatitis—Clonazepam—epilepsy syndrome	0.000338	0.00159	CcSEcCtD
Fluocinonide—Dizziness—Carbamazepine—epilepsy syndrome	0.000336	0.00158	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	0.000336	0.00305	CbGpPWpGaD
Fluocinonide—Headache—Clonazepam—epilepsy syndrome	0.000336	0.00158	CcSEcCtD
Fluocinonide—Rash—Phenytoin—epilepsy syndrome	0.000336	0.00158	CcSEcCtD
Fluocinonide—Dermatitis—Phenytoin—epilepsy syndrome	0.000335	0.00158	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000335	0.00158	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.000335	0.00304	CbGpPWpGaD
Fluocinonide—Rash—Oxcarbazepine—epilepsy syndrome	0.000334	0.00157	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—JUNB—epilepsy syndrome	0.000334	0.00303	CbGpPWpGaD
Fluocinonide—Pain—Valproic Acid—epilepsy syndrome	0.000334	0.00157	CcSEcCtD
Fluocinonide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000334	0.00157	CcSEcCtD
Fluocinonide—Headache—Phenytoin—epilepsy syndrome	0.000334	0.00157	CcSEcCtD
Fluocinonide—Erythema—Topiramate—epilepsy syndrome	0.000334	0.00157	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—AVP—epilepsy syndrome	0.000333	0.00302	CbGpPWpGaD
Fluocinonide—Headache—Oxcarbazepine—epilepsy syndrome	0.000332	0.00156	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—TH—epilepsy syndrome	0.000332	0.00301	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCR2—epilepsy syndrome	0.000329	0.00299	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—SST—epilepsy syndrome	0.000329	0.00299	CbGpPWpGaD
Fluocinonide—Dizziness—Lamotrigine—epilepsy syndrome	0.000325	0.00153	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.000323	0.00293	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000322	0.00292	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000321	0.00292	CbGpPWpGaD
Fluocinonide—Infection—Gabapentin—epilepsy syndrome	0.000321	0.00151	CcSEcCtD
Fluocinonide—Flurandrenolide—NR3C1—epilepsy syndrome	0.000321	0.0364	CrCbGaD
Fluocinonide—Rash—Carbamazepine—epilepsy syndrome	0.00032	0.00151	CcSEcCtD
Fluocinonide—Dermatitis—Carbamazepine—epilepsy syndrome	0.00032	0.0015	CcSEcCtD
Fluocinonide—Headache—Carbamazepine—epilepsy syndrome	0.000318	0.0015	CcSEcCtD
Fluocinonide—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000317	0.00149	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PRDM4—epilepsy syndrome	0.000317	0.00288	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000317	0.00288	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	0.000316	0.00287	CbGpPWpGaD
Fluocinonide—Flumethasone Pivalate—NR3C1—epilepsy syndrome	0.000316	0.0358	CrCbGaD
Fluocinonide—Skin disorder—Gabapentin—epilepsy syndrome	0.000314	0.00148	CcSEcCtD
Fluocinonide—Halobetasol Propionate—NR3C1—epilepsy syndrome	0.000311	0.0352	CrCbGaD
Fluocinonide—Rash—Lamotrigine—epilepsy syndrome	0.00031	0.00146	CcSEcCtD
Fluocinonide—Dermatitis—Lamotrigine—epilepsy syndrome	0.000309	0.00145	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000309	0.00281	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000309	0.00281	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000308	0.0028	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000308	0.0028	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR9—epilepsy syndrome	0.000308	0.0028	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000308	0.0028	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR8—epilepsy syndrome	0.000308	0.0028	CbGpPWpGaD
Fluocinonide—Headache—Lamotrigine—epilepsy syndrome	0.000308	0.00145	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—MEF2C—epilepsy syndrome	0.000304	0.00276	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CNR1—epilepsy syndrome	0.000304	0.00276	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRM3—epilepsy syndrome	0.000302	0.00274	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRM4—epilepsy syndrome	0.000302	0.00274	CbGpPWpGaD
Fluocinonide—Pain—Pregabalin—epilepsy syndrome	0.000302	0.00142	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000297	0.00269	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR7—epilepsy syndrome	0.000296	0.00269	CbGpPWpGaD
Fluocinonide—Amcinonide—NR3C1—epilepsy syndrome	0.000289	0.0327	CrCbGaD
Fluocinonide—Budesonide—NR3C1—epilepsy syndrome	0.000289	0.0327	CrCbGaD
Fluocinonide—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000288	0.00135	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—GRM8—epilepsy syndrome	0.000287	0.0026	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	0.000286	0.00259	CbGpPWpGaD
Fluocinonide—Fluticasone furoate—NR3C1—epilepsy syndrome	0.000283	0.0321	CrCbGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000282	0.00133	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—ACKR4—epilepsy syndrome	0.000277	0.00251	CbGpPWpGaD
Fluocinonide—Pain—Gabapentin—epilepsy syndrome	0.000277	0.0013	CcSEcCtD
Fluocinonide—Pruritus—Valproic Acid—epilepsy syndrome	0.000276	0.0013	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.000275	0.00249	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.000275	0.00249	CbGpPWpGaD
Fluocinonide—Mometasone—NR3C1—epilepsy syndrome	0.000275	0.0311	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000273	0.00248	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000273	0.00248	CbGpPWpGaD
Fluocinonide—Rimexolone—NR3C1—epilepsy syndrome	0.000272	0.0307	CrCbGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	0.000271	0.00246	CbGpPWpGaD
Fluocinonide—Infection—Topiramate—epilepsy syndrome	0.00027	0.00127	CcSEcCtD
Fluocinonide—Nervous system disorder—Topiramate—epilepsy syndrome	0.000267	0.00125	CcSEcCtD
Fluocinonide—Skin disorder—Topiramate—epilepsy syndrome	0.000264	0.00124	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PDYN—epilepsy syndrome	0.000262	0.00238	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRM1—epilepsy syndrome	0.000262	0.00238	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000262	0.00238	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR7—epilepsy syndrome	0.000262	0.00238	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Pregabalin—epilepsy syndrome	0.00026	0.00122	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—BMP4—epilepsy syndrome	0.000259	0.00235	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.000259	0.00235	CbGpPWpGaD
Fluocinonide—Dizziness—Valproic Acid—epilepsy syndrome	0.000258	0.00121	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	0.000258	0.00234	CbGpPWpGaD
Fluocinonide—Beclomethasone—NR3C1—epilepsy syndrome	0.000256	0.029	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—SSTR5—epilepsy syndrome	0.000251	0.00227	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SSTR4—epilepsy syndrome	0.000251	0.00227	CbGpPWpGaD
Fluocinonide—Pruritus—Pregabalin—epilepsy syndrome	0.00025	0.00117	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—AVP—epilepsy syndrome	0.000249	0.00226	CbGpPWpGaD
Fluocinonide—Fluocinolone Acetonide—NR3C1—epilepsy syndrome	0.000249	0.0282	CrCbGaD
Fluocinonide—Dexamethasone—SLCO1A2—epilepsy syndrome	0.000249	0.0282	CrCbGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—epilepsy syndrome	0.000248	0.00225	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GAL—epilepsy syndrome	0.000246	0.00224	CbGpPWpGaD
Fluocinonide—Rash—Valproic Acid—epilepsy syndrome	0.000246	0.00116	CcSEcCtD
Fluocinonide—Dermatitis—Valproic Acid—epilepsy syndrome	0.000246	0.00116	CcSEcCtD
Fluocinonide—Headache—Valproic Acid—epilepsy syndrome	0.000245	0.00115	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000244	0.00221	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRM5—epilepsy syndrome	0.000244	0.00221	CbGpPWpGaD
Fluocinonide—Clobetasol propionate—NR3C1—epilepsy syndrome	0.000242	0.0274	CrCbGaD
Fluocinonide—Flunisolide—NR3C1—epilepsy syndrome	0.000242	0.0274	CrCbGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—epilepsy syndrome	0.000241	0.00219	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR10—epilepsy syndrome	0.00024	0.00218	CbGpPWpGaD
Fluocinonide—Paramethasone—NR3C1—epilepsy syndrome	0.000239	0.0271	CrCbGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	0.000239	0.00217	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000238	0.00112	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	0.000236	0.00214	CbGpPWpGaD
Fluocinonide—Ciclesonide—NR3C1—epilepsy syndrome	0.000236	0.0267	CrCbGaD
Fluocinonide—Triamcinolone—BCHE—epilepsy syndrome	0.000235	0.0266	CrCbGaD
Fluocinonide—Fluorometholone—NR3C1—epilepsy syndrome	0.000234	0.0264	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000234	0.00212	CbGpPWpGaD
Fluocinonide—Dizziness—Pregabalin—epilepsy syndrome	0.000233	0.0011	CcSEcCtD
Fluocinonide—Pain—Topiramate—epilepsy syndrome	0.000233	0.00109	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	0.000232	0.00211	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.000232	0.00211	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000229	0.00208	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000229	0.00208	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000229	0.00208	CbGpPWpGaD
Fluocinonide—Pruritus—Gabapentin—epilepsy syndrome	0.000229	0.00108	CcSEcCtD
Fluocinonide—Methylprednisolone—NR3C1—epilepsy syndrome	0.000226	0.0256	CrCbGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	0.000223	0.00202	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000223	0.00202	CbGpPWpGaD
Fluocinonide—Rash—Pregabalin—epilepsy syndrome	0.000222	0.00105	CcSEcCtD
Fluocinonide—Dermatitis—Pregabalin—epilepsy syndrome	0.000222	0.00104	CcSEcCtD
Fluocinonide—Headache—Pregabalin—epilepsy syndrome	0.000221	0.00104	CcSEcCtD
Fluocinonide—Dexamethasone—CYP11A1—epilepsy syndrome	0.000217	0.0245	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—AGT—epilepsy syndrome	0.000216	0.00196	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—PLAU—epilepsy syndrome	0.000215	0.00195	CbGpPWpGaD
Fluocinonide—Dizziness—Gabapentin—epilepsy syndrome	0.000214	0.00101	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—HRH3—epilepsy syndrome	0.000214	0.00194	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCR5—epilepsy syndrome	0.000212	0.00192	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.000211	0.00191	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OPRM1—epilepsy syndrome	0.00021	0.00191	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM2—epilepsy syndrome	0.00021	0.00191	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	0.000208	0.00189	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000208	0.00188	CbGpPWpGaD
Fluocinonide—Rash—Gabapentin—epilepsy syndrome	0.000204	0.000959	CcSEcCtD
Fluocinonide—Dermatitis—Gabapentin—epilepsy syndrome	0.000204	0.000958	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	0.000203	0.00184	CbGpPWpGaD
Fluocinonide—Headache—Gabapentin—epilepsy syndrome	0.000203	0.000952	CcSEcCtD
Fluocinonide—Hypersensitivity—Topiramate—epilepsy syndrome	0.000201	0.000942	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CCR3—epilepsy syndrome	0.000199	0.0018	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—AGT—epilepsy syndrome	0.000197	0.00179	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.000196	0.00178	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NPY—epilepsy syndrome	0.000194	0.00176	CbGpPWpGaD
Fluocinonide—Pruritus—Topiramate—epilepsy syndrome	0.000193	0.000905	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000191	0.00173	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000191	0.00173	CbGpPWpGaD
Fluocinonide—Triamcinolone—NR3C1—epilepsy syndrome	0.00019	0.0216	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—SSTR3—epilepsy syndrome	0.00019	0.00172	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.00019	0.00172	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000187	0.00169	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CRH—epilepsy syndrome	0.000187	0.00169	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OXT—epilepsy syndrome	0.000187	0.00169	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL3—epilepsy syndrome	0.000187	0.00169	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000186	0.00169	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	0.000183	0.00166	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SSTR1—epilepsy syndrome	0.000182	0.00165	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR9—epilepsy syndrome	0.000182	0.00165	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000182	0.00165	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPY2R—epilepsy syndrome	0.000182	0.00165	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR8—epilepsy syndrome	0.000182	0.00165	CbGpPWpGaD
Fluocinonide—Dizziness—Topiramate—epilepsy syndrome	0.00018	0.000846	CcSEcCtD
Fluocinonide—Dexamethasone—NOS2—epilepsy syndrome	0.000179	0.0203	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—GRM3—epilepsy syndrome	0.000179	0.00162	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM4—epilepsy syndrome	0.000179	0.00162	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	0.000178	0.00162	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DUSP4—epilepsy syndrome	0.000175	0.00159	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SSTR2—epilepsy syndrome	0.000175	0.00159	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.000175	0.00158	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	0.000174	0.00158	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	0.000173	0.00157	CbGpPWpGaD
Fluocinonide—Rash—Topiramate—epilepsy syndrome	0.000172	0.000807	CcSEcCtD
Fluocinonide—Dermatitis—Topiramate—epilepsy syndrome	0.000171	0.000806	CcSEcCtD
Fluocinonide—Headache—Topiramate—epilepsy syndrome	0.000171	0.000801	CcSEcCtD
Fluocinonide—Fluticasone Propionate—NR3C1—epilepsy syndrome	0.00017	0.0193	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—GRM8—epilepsy syndrome	0.000169	0.00154	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PGF—epilepsy syndrome	0.000169	0.00154	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR2—epilepsy syndrome	0.000169	0.00153	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—SST—epilepsy syndrome	0.000169	0.00153	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—POMC—epilepsy syndrome	0.000166	0.0015	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000165	0.0015	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	0.000164	0.00149	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	0.000162	0.00147	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL2—epilepsy syndrome	0.000162	0.00147	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OPRD1—epilepsy syndrome	0.000161	0.00146	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GNAO1—epilepsy syndrome	0.000161	0.00146	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	0.000161	0.00146	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	0.000161	0.00146	CbGpPWpGaD
Fluocinonide—Ciclesonide—CYP2D6—epilepsy syndrome	0.000159	0.018	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000159	0.00144	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000159	0.00144	CbGpPWpGaD
Fluocinonide—Betamethasone—NR3C1—epilepsy syndrome	0.000156	0.0177	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—CNR1—epilepsy syndrome	0.000156	0.00141	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000155	0.00141	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CHRM1—epilepsy syndrome	0.000155	0.0014	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR7—epilepsy syndrome	0.000155	0.0014	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDYN—epilepsy syndrome	0.000155	0.0014	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM1—epilepsy syndrome	0.000155	0.0014	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	0.000153	0.00139	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR7—epilepsy syndrome	0.000152	0.00138	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000148	0.00134	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	0.000147	0.00133	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GFAP—epilepsy syndrome	0.000146	0.00132	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GAL—epilepsy syndrome	0.000146	0.00132	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT3—epilepsy syndrome	0.000145	0.00131	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.000144	0.00131	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP2—epilepsy syndrome	0.000144	0.00131	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM5—epilepsy syndrome	0.000144	0.00131	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CHRM3—epilepsy syndrome	0.000144	0.00131	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000142	0.00129	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000138	0.00125	CbGpPWpGaD
Fluocinonide—Fluticasone furoate—ABCB1—epilepsy syndrome	0.000137	0.0155	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.000137	0.00124	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CHRM2—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—WARS—epilepsy syndrome	0.000135	0.00122	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CDC42—epilepsy syndrome	0.000132	0.0012	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000132	0.0012	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—AGT—epilepsy syndrome	0.000132	0.0012	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	0.000132	0.0012	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GABBR1—epilepsy syndrome	0.000132	0.00119	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	0.000131	0.00119	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	0.00013	0.00118	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AVP—epilepsy syndrome	0.000128	0.00116	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000128	0.00116	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	0.000127	0.00116	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000126	0.00115	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HRH3—epilepsy syndrome	0.000126	0.00114	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OPRM1—epilepsy syndrome	0.000124	0.00113	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	0.000121	0.0011	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.00012	0.00109	CbGpPWpGaD
Fluocinonide—Dexamethasone—ABCC2—epilepsy syndrome	0.000119	0.0135	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—CCR3—epilepsy syndrome	0.000117	0.00106	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	0.000117	0.00106	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	0.000115	0.00105	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPY—epilepsy syndrome	0.000114	0.00104	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000114	0.00104	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OXT—epilepsy syndrome	0.00011	0.001	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL3—epilepsy syndrome	0.00011	0.001	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CRH—epilepsy syndrome	0.00011	0.001	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HSPB1—epilepsy syndrome	0.00011	0.001	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL2—epilepsy syndrome	0.00011	0.001	CbGpPWpGaD
Fluocinonide—Methylprednisolone—ABCB1—epilepsy syndrome	0.000109	0.0123	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—CCR5—epilepsy syndrome	0.000109	0.000987	CbGpPWpGaD
Fluocinonide—Triamcinolone—PTGS2—epilepsy syndrome	0.000108	0.0122	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000106	0.000966	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	0.000106	0.000961	CbGpPWpGaD
Fluocinonide—Dexamethasone—ABCG2—epilepsy syndrome	0.000105	0.0119	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—TSC1—epilepsy syndrome	0.000103	0.00093	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTK2B—epilepsy syndrome	0.000103	0.00093	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—QARS—epilepsy syndrome	0.000102	0.000926	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AGT—epilepsy syndrome	0.000101	0.000917	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SST—epilepsy syndrome	9.98e-05	0.000905	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR2—epilepsy syndrome	9.98e-05	0.000905	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTRK2—epilepsy syndrome	9.98e-05	0.000905	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DUSP6—epilepsy syndrome	9.89e-05	0.000897	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADRA2A—epilepsy syndrome	9.76e-05	0.000886	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLAT—epilepsy syndrome	9.72e-05	0.000882	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BDKRB2—epilepsy syndrome	9.38e-05	0.000851	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL12—epilepsy syndrome	9.38e-05	0.000851	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PRKCB—epilepsy syndrome	9.34e-05	0.000847	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6ST—epilepsy syndrome	9.3e-05	0.000844	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JUNB—epilepsy syndrome	9.21e-05	0.000835	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR1—epilepsy syndrome	9.21e-05	0.000835	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLCB1—epilepsy syndrome	9.17e-05	0.000832	CbGpPWpGaD
Fluocinonide—Dexamethasone—NR3C1—epilepsy syndrome	9.08e-05	0.0103	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—HTR7—epilepsy syndrome	8.98e-05	0.000815	CbGpPWpGaD
Fluocinonide—Betamethasone—PTGS2—epilepsy syndrome	8.85e-05	0.01	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—HBEGF—epilepsy syndrome	8.72e-05	0.000791	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT3—epilepsy syndrome	8.56e-05	0.000776	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—POMC—epilepsy syndrome	8.5e-05	0.000772	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADAM10—epilepsy syndrome	8.36e-05	0.000758	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL2—epilepsy syndrome	8.32e-05	0.000755	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP2C19—epilepsy syndrome	8.27e-05	0.00936	CrCbGaD
Fluocinonide—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	8.16e-05	0.00074	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—S100B—epilepsy syndrome	7.91e-05	0.000717	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SOCS3—epilepsy syndrome	7.83e-05	0.00071	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDC42—epilepsy syndrome	7.81e-05	0.000708	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AVP—epilepsy syndrome	7.56e-05	0.000686	CbGpPWpGaD
Fluocinonide—Betamethasone—ABCB1—epilepsy syndrome	7.53e-05	0.00852	CrCbGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	7.43e-05	0.000674	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—TFAM—epilepsy syndrome	7.38e-05	0.000669	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HES1—epilepsy syndrome	7.15e-05	0.000649	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	7.12e-05	0.000646	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	7.11e-05	0.000645	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FYN—epilepsy syndrome	6.95e-05	0.000631	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—H2AFX—epilepsy syndrome	6.93e-05	0.000628	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MEF2C—epilepsy syndrome	6.91e-05	0.000627	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	6.9e-05	0.000626	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—YWHAZ—epilepsy syndrome	6.68e-05	0.000606	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NGF—epilepsy syndrome	6.61e-05	0.0006	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	6.5e-05	0.00059	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	6.44e-05	0.000584	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR5—epilepsy syndrome	6.43e-05	0.000583	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	6.37e-05	0.000578	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2A—epilepsy syndrome	6.29e-05	0.000571	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP2D6—epilepsy syndrome	6.13e-05	0.00694	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.03e-05	0.000547	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—epilepsy syndrome	5.98e-05	0.000542	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TSC2—epilepsy syndrome	5.98e-05	0.000542	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AGT—epilepsy syndrome	5.97e-05	0.000542	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	5.9e-05	0.000535	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—epilepsy syndrome	5.85e-05	0.000531	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KDR—epilepsy syndrome	5.73e-05	0.00052	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRKCB—epilepsy syndrome	5.52e-05	0.0005	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6ST—epilepsy syndrome	5.49e-05	0.000498	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.17e-05	0.000469	CbGpPWpGaD
Fluocinonide—Dexamethasone—PTGS2—epilepsy syndrome	5.15e-05	0.00583	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—POMC—epilepsy syndrome	5.02e-05	0.000456	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL2—epilepsy syndrome	4.92e-05	0.000446	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	4.44e-05	0.000403	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF2—epilepsy syndrome	4.44e-05	0.000403	CbGpPWpGaD
Fluocinonide—Dexamethasone—ABCB1—epilepsy syndrome	4.38e-05	0.00496	CrCbGaD
Fluocinonide—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	4.29e-05	0.000389	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RELA—epilepsy syndrome	4.12e-05	0.000374	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MTOR—epilepsy syndrome	4.04e-05	0.000367	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—epilepsy syndrome	3.72e-05	0.000337	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JUN—epilepsy syndrome	3.61e-05	0.000328	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—JUNB—epilepsy syndrome	3.58e-05	0.000325	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—epilepsy syndrome	3.52e-05	0.000319	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—epilepsy syndrome	3.41e-05	0.000309	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SRC—epilepsy syndrome	3.24e-05	0.000294	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—epilepsy syndrome	3.16e-05	0.000286	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	2.88e-05	0.000261	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—VDR—epilepsy syndrome	2.84e-05	0.000258	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	2.69e-05	0.000244	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	2.6e-05	0.000236	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—epilepsy syndrome	2.01e-05	0.000183	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—epilepsy syndrome	7.83e-06	7.1e-05	CbGpPWpGaD
